Skip to main content
. 2014 Oct 3;9(10):e104828. doi: 10.1371/journal.pone.0104828

Table 4. Pharmaceutical financial sponsoring.

Statement Strongly disagree, n (%) Disagree, n (%) Neutral, n (%) Agree, n (%) Strongly agree, n (%)
It is acceptable that a medical Professor receive money from drug companies for medical congress (n = 624) 143 (22.9) 110 (17.6) 152 (24.4) 148 (23.7) 71 (11.4)
Since students from non-medical universities are invited to meetings and meals by private companies, medical residents should be allowed to attend similar arrangements with pharmaceutical industry (n = 627) 79 (12.6) 72 (11.5) 166 (26.5) 135 (21.5) 175 (27.9)
It is acceptable that medical residents receive financial sponsoring from drug companies, because they haven't enough money to be informed (n = 625) 162 (25.9) 92 (14.7) 107 (17.1) 144 (23.1) 120 (19.2)
It is acceptable that medical residents receive financial sponsoring from drug companies, because drug companies have minimal influence on residents (n = 626) 199 (31.8) 156 (24.9) 109 (17.4) 112 (17.9) 50 (8.0)